text:
Scleroderma and Other Fibrosing Conditions
Flavia V. Castelino
Does this patient have scleroderma?
The term scleroderma comes from the Greek "skleros", meaning hard, and "derma", meaning skin. Patients with scleroderma experience thickening and hardening of the skin which occurs due to excessive collagen deposition and fibrosis of the skin.
Scleroderma is a term which encompasses several syndromes, and is subdivided into localized scleroderma or systemic sclerosis. Localized forms of scleroderma include morphea, linear scleroderma or en coup de sabre, where involvement is just limited to the skin and subcutaneous tissues without internal organ system involvement. Systemic sclerosis (SSc) is divided into limited and diffuse forms where specific patterns of skin involvement are observed in addition to specific internal organ system (lungs, heart, gastrointestinal tract) involvement. However, similar features of hard and thick skin can be seen in other conditions which are often referred to as "scleroderma mimics". These mimics include eosinophilic fasciitis, nephrogenic systemic fibrosis, scleromyxedema, and scleredema among others.
This article will focus on the diagnosis and treatment of diffuse cutaneous Systemic Sclerosis (dcSSc), eosinophilic fasciitis (EF), and generalized morphea (GM) as three cutaneous fibrosing syndromes seen with wide-spread skin involvement.
The exact pathogenenic mechanisms for most of these conditions are not well understood. Treatment and prognosis for these conditions vary, and it is important to differentiate among these disorders. Certain clinical features can be used to make the correct diagnosis. These include the clinical presentation, distribution of skin involvement, the presence of Raynaud's phenomenon (RP) and nailfold capillary abnormalities, and the extent of internal organ involvement. The diagnosis is additionally supported by specific laboratory abnormalities including autoantibodies, radiographic features, and pathology if available.
Systemic Sclerosis – diffuse and limited
SSc is a rare condition occurring in 7-489 persons per million. It affects the population at any age; however, the most common incidence occurs between ages 30-50. It is seen in a female to male ratio of 3:1.
In dcSSc early clinical symptoms include painful and/or puffy swollen hands, RP, and numbness in the fingers. These initial symptoms are frequently followed by progression of skin tightening and involvement of multiple other internal organs. In limited cutaneous (lc) SSc, patients tend to have RP for many years prior to the onset of additional symptoms. Patients with dcSSc by definition have involvement of the skin proximal to the elbows and knees, the face, chest, and abdomen. However, either early or late in the course of the disease, the skin involvement may not include all these areas. In lcSSc the skin thickening is limited to the face and areas distal to the elbows and knees.
Patients with SSc usually have internal organ involvement. Patients can develop scleroderma renal crisis (SRC), interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), cardiac disease (including fibrosis and arrhythmia), and gastrointestinal (GI) involvement, which may occur at any point along the GI tract from mouth to anus, and frequently includes symptoms of reflux and dysphagia. Additional symptoms may include weight loss, digital ulceration, development of telangiectasias, skin hyperpigmentation or hypopigmentation. Renal crisis and cardiac involvement are more common in those with the diffuse subtype, but other organ involvement is seen in both subtypes. Musculoskeletal involvement including arthritis, joint contractures, and myopathy can additionally occur.
Physical examination findings are very helpful. In early stages, diffuse puffiness or swelling of the hands is frequently observed. If this is seen in conjunction with RP and nailfold capillary dilatation, a high suspicion for scleroderma should be maintained, although it is possible to see such changes in dermatomyositis and mixed connective tissue disease, and occasionally in SLE, especially if there is an overlap condition. With respect to skin thickening and tightness, it is common for the hands to be involved early on. Associated symptoms are pain, numbness and clumsiness of the hands.
Although most patients who develop SSc have RP, it may be absent early in the course of the disease, especially in those patients with the RNA polymerase III antibody who may develop RP later in the disease course. Additionally nailfold capillary changes are helpful if present but are not always seen. The skin thickening tends to progress from the fingers and hands to the forearms and upper arms, to eventually involve the chest and abdomen. The face is usually involved early at the same time as the hands. Feet and lower extremities are frequently involved as well.
EF, also known as Schulman syndrome, is an uncommon condition whose true incidence is not known. It occurs in adults from age 20-50 and is seen in a female to male ratio of 1:2. The cutaneous changes associated with EF usually occur rapidly and are seen in association with elevated inflammatory markers, blood and tissue eosinophilia, and hypergammaglobulinemia. Different triggers have been suggested for EF and include preceding trauma, vigorous exercise or infection with Borrelia burgdorferii. Toxic exposure with L-tryptophan or toxic rapeseed oil have previously been reported to produce a self-limited EF-like illness. EF can be seen in association with other immunologic phenomena including immune-mediated cytopenias and morphea. In 10-15% of patients with EF, hematologic disorders including malignancies are discovered.
In general, the clinical onset of EF is rapid, with symmetric and inflammatory skin thickening, followed by edema and dimpling of the skin often referred to as a peau d'orange appearance. Over a period of days to weeks this process develops over the forearms and legs and can progress to include the upper arms, thighs, trunk and neck. Usually the face and hands are spared. The skin becomes progressively indurated and involvement of the deeper fascial layers and muscle can cause puckering and venous furrowing. The epidermis tends not to be involved, and this can be observed with palpation of the skin leading to a wrinkling of the epidermis.
The deep involvement of the subcutaneous structures and fascia can lead to the rapid development of severe flexion contractures and it is important that prompt physical therapy be instituted at the onset of treatment. Raynaud's phenomenon tends to be absent, and inflammatory arthritis may sometimes be present early in this condition. Systemic symptoms including fatigue, malaise, and weight loss. Internal organ involvement is not generally observed, and, if present, should increase suspicion for SSc.
Generalized morphea (GM) is a subtype of localized scleroderma, and is a rare disorder that affects children and adults. Morphea of any type has a yearly incidence of approximately 3/100,000 persons, and GM is estimated to occur in 8% of these cases. There is a female to male predominance of 2.6:1 and more than half the cases are seen in children.
GM usually presents with erythematous, inflammatory, and sometimes pruritic patches on the chest, abdomen, back, and limbs. GM, in contrast to other types of morphea, is defined by the presence of ≥4 morpheaform plaques at 2 or more anatomic sites. The lesions tend to start on the trunk and may spread to involve the limbs centrifugally. The fingers and toes are generally not involved, and this helps distinguish the syndrome from SSc. The plaques later become sclerotic and bound-down. The lesions may also appear hypo-pigmented, hyper-pigmented, or shiny, and hair-loss in these affected areas is common. In pansclerotic morphea, the lesions are deeper, involving the subcutis, are circumferential, and may involve most of the body surface, excluding the fingers and toes. After months to years, the plaques soften and may atrophy.
The joints can be involved in morphea with evidence of arthritis or arthralgias. RP has been reported in a minority of patients, therefore this cannot be used as a point of differentiation from SSc, although RP is vastly more common in SSc than GM. In general, the internal organs are spared in GM. A significant proportion of patients have antinuclear antibody positivity.
Autoantibodies are helpful in confirming the diagnosis of SSc and have prognostic value. However, a negative autoantibody profile does not exclude disease. Autoantibodies are seen in approximately 90-95% of SSc patients. It is important to note that certain commercial laboratories' multiplex antinuclear antibodies (ANAs) miss nucleolar ANAs, and ordering an ANA by immunofluorescence is preferable in this context.
There are at least 7 scleroderma specific autoantibodies, with predictive values for various demographic, clinical, and organ system involvement. The antibodies do not change over the course of the illness. An anti-topoisomerase I (anti-Scl70) antibody occurs in approximately 15-40% of all scleroderma patients, and is associated with diffuse SSc and interstitial lung disease. An anti-centromere pattern, also seen in about 20-40% of SSc patients, is strongly associated with the limited cutaneous SSc subtype, and is associated with pulmonary arterial hypertension. An anti-RNA polymerase III antibody is present in approximately 10% of all patients with SSc and is associated with severe and rapid skin progression, malignancy and an increased likelihood for scleroderma renal crisis. U1RNP is seen in 5% of scleroderma patients, and is also present in patients with mixed connective tissue disease, or with joint and muscle disease.
Although these autoantibodies are specific for SSc they are not sensitive, and their absence does not rule out a diagnosis of SSc. Other autoantibodies (PM-Scl, Th/To, U3RNP) are only available through specialized laboratories. The antibodies are usually mutually exclusive, and if present argue strongly for a diagnosis of SSc in the correct clinical context. Some patients with SSc can have serological and clinical overlap with other connective tissue diseases. Lupus specific autoantibodies (Smith, dsDNA) are seen if there is overlap with other connective tissue disease, and anti-CCP antibodies are seen in overlap with rheumatoid arthritis. Ro antibodies and RF can be seen in scleroderma alone and do not predicate overlap per se. In SSc the presence of anti-B2-glycoprotein 1 antibodies is a risk factor for macrovascular disease.
Peripheral eosinophilia is present in 80% of cases and can be transient. Also observed are elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), hypergammaglobulinemia. Creatine kinase (CK) levels are typically normal. Serum ANAs are typically negative. Hematologic abnormalities should be investigated and association with blood dyscrasias can occur in up to 10% of patients.
Severity of skin involvement is assessed by the modified Rodnan skin score (MRSS), in which a trained observer measures skin thickness by palpation of 17 areas of skin and grades the skin in severity from 0 (normal) to 3 (severely thickened), where 1 and 2 are mild and moderate thickening, giving a score from 0-51. The MRSS is used in clinical trials to assess response to treatment, but its role in clinical practice has not been delineated.
Specific testing is important in categorizing organ involvement at the time of diagnosis and should be performed periodically in patients with dcSSc. Pulmonary function testing (PFT), trans thoracic echocardiography (TTE) with measurement of pulmonary arterial pressure, electrocardiogram, and high resolution CT of the chest are useful in the evaluation of interstitial lung disease (ILD), pulmonary hypertension (PH), and heart disease. These studies are typically performed at the time of diagnosis.
Annual TTE and PFTs is typically done in every patient. PFTs every 6-12 months can be considered especially in high risk patients and if symptoms develop or progress. Although TTE is frequently utilized to screen for PH, correlation between right ventricular systolic pressure measured by TTE and pulmonary artery pressure measurements on right heart catheterization (RHC) is generally poor. Analysis of B-type natriuretic peptide may help in certain circumstances. Most patients with dcSSc will need these studies performed at least annually.
The evaluation of GI symptoms is driven based on the presence and type of symptoms. This evaluation frequently includes endoscopy and barium swallow and other lower GI studies as indicated based on clinical concerns.
Biopsy of the skin is helpful in certain cases of dcSSc if the skin lesions are atypical or if the clinical picture is not clear. A skin biopsy is not required for the diagnosis of dcSSc.
A diagnosis of EF can be made with a full-thickness skin biopsy performed by a dermatologist or general surgeon. It is important that the biopsy is deep enough to include the fascia; this is generally not accomplished by a punch biopsy. There is no pathognomonic finding of EF on biopsy. Typically, the epidermis is spared and often there is dermal-hypodermal sclerosis with fibrotic thickening extending down to the fascia. Inflammatory infiltrates may also be present and include eosinophils. If corticosteroid therapy has been initiated, eosinophils are frequently absent. MRI of the affected areas can also be helpful in the diagnosis of EF, and shows clear involvement of the fascia and deep structures.
In GM, a skin biopsy can be helpful in the diagnosis, but it is not required in the correct clinical context. The biopsy should be performed in such a way that it includes the subcutis, and thus an incisional biopsy is generally superior to a punch biopsy in case of deep tissue involvement.
How should patients be managed?
There are currently no approved targeted therapies for the treatment of scleroderma. Treatment strategies have focused on traditional immunosuppressive therapies that have proven efficacy in other rheumatic conditions. The treatment of dcSSc depends on specific organ involvement and clinical manifestations.
With respect to RP and digital ulceration, dihydropyridine calcium channel blockers (CCBs) (usually nifedipine or amlodipine) are considered first-line. With nitroglycerin and phosphodiesterase inhibitors considered second-line agents. These agents can be used in combination with CCBs.
Additional agents sometimes employed include aspirin, pentoxifylline and bosentan. Bosentan has been shown to prevent the onset of new digital ulcers in two randomized controlled trials (RCTs), but it was not shown to improve healing of active digital ulcers. Intravenous iloprost, an analog of PGI2 (prostaglandin I2), may be helpful in the case of severe RP and can be given in an outpatient setting (0.5-3 ng/kg per minute for 3-5 consecutive days sequentially), although frequently requires inpatient admission at most centers. It is important to note that this dosing regimen is contraindicated in patients with pulmonary hypertension. Additional approaches with anecdotal benefit include sympathectomy (either via nerve blockade or via a surgical approach).
The two best studied medications in the treatment of SSc, and specifically SSc-ILD, have been cyclophosphamide (CYC) and mycophenolate mofetil (MMF). In the Scleroderma Lung Study (SLS) I, a year of treatment with oral CYC for SSc-ILD was found to be modestly better than placebo in stabilizing FVC at one year. However, in a follow-up study this effect was reduced at 2 years, suggesting a transient benefit. In the recently completed Scleroderma Lung Study II, MMF was compared to CYC for the treatment of SSc-ILD. MMF was found to be non-inferior to CYC with comparable improvements in FVC in both treatment groups at 24 months. Of note, the mRSS improved in both treatment arms with a trend favoring CYC. Based on the results of these two trials, first line treatment for progressive SSc-ILD will likely shift from CYC to MMF given its more favorable side effect profile. MMF has separately been evaluated for the treatment of scleroderma skin disease, albeit in small cohorts and may have beneficial effects on lowering skin score, particularly in patients with early dcSSc. A recent post-hoc analysis of the SLS II showed that both MMF and CYC had statistically significant improvements in mRSS in patients with dcSSc at 24 months.
Other traditional disease modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) have been evaluated in scleroderma. A small randomized, controlled trial compared one year of methotrexate to placebo in patients with early (< 3 years) diffuse scleroderma. Despite the small size of the study, there was a trend towards improvement in the mRSS in the MTX group. The European League Against Rheumatism (EULAR) and European Scleroderma Trial and Research Group (EUSTAR) recommend MTX for skin disease in patients with early dcSSc.
Rituximab, a monoclonal antibody against CD20, used in the treatment of rheumatoid arthritis and ANCA associated vasculitis, has come of interest in the treatment of SSc. A small nested case-control study demonstrated that patients treated with Rituximab versus matched controls had improvement in their mRSS, and prevented further decline of FVC in a small subset of patients with ILD. While Rituximab may be beneficial in SSc, larger studies are needed.
In light of recent advances in the understanding of the pathogenesis of SSc, new antifibrotic agents are currently in development and have entered Phase II and III trials. Some of the newer drugs include fresolimumab, a monoclonal antibody to TGF-beta, an LPA1 antagonist, SAR100842, tocilizumab, a monoclonal antibody against the IL-6 receptor. These drugs have shown promise in early phase trials with improvement in skin scores.
Two recently approved drugs for idiopathic pulmonary fibrosis, pirfenidone and nintedanib are now being studied in SSc-ILD. A Phase II trial of pirfenidone in SSc-ILD (LOTUSS) was completed and showed acceptable tolerability, even with over 60% of patients concurrently taking MMF. A Phase III trial of nintedanib in SSc-ILD is currently ongoing.
Given the relatively poor prognosis of SSc-ILD and the historic lack of targeted therapies for the disease, autologous hematopoietic stem cell transplant (HSCT) presents a potentially attractive therapeutic option. Three major trials have compared HSCT to CYC in SSc patients with internal organ involvement. ASSIST (Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial), a single center study, found that patients with dcSSc and internal organ involvement treated with HSCT compared to IV CYC for 6 months had improvement in skin scores and FVC at 12 months. The ASTIS (Autologous Stem cell Transplantation International Scleroderma) trial, a multi-center study in Europe and Canada, found that dcSSc patients treated with HSCT had improved event-free and overall survival despite a 10% treatment related mortality in the HSCT group, when compared to one year of IV CYC. The SCOT (Scleroderma: Cyclophosphamide Or Transplantation) trial, a multi-center study in North America, comparing IV cyclophosphamide for 1 year with HSCT, found that there was long-term superiority to myeloablative HSCT with lower transplant related mortality than expected (3%). HSCT may be considered for patients with severe disease who have been refractory to other treatment options.
Pulmonary hypertension is another leading cause of morbidity and mortality in SSc. The WHO (World Health Organization) has developed a functional classification system to categorize PAH according to its clinical symptoms and severity. In general, oral therapy is recommended for patients with functional class (FC) II or higher, and the goal of treatment is to improve functional class. Current therapies for SSc-PAH target the vasoconstrictive and vasodilatory mediators produced by the dysfunctional endothelium. The three main targeted pathways for the treatment of SSc-PAH include the nitric oxide pathway (phosphodiesterase type 5 inhibitors- sildenafil, tadalafil), the endothelin pathway (bosentan, ambrisentan) and the prostacyclin pathway (epoprostenol, iloprost, selexipag). It is important to note that many of the large randomized trials in PAH have not been designed or powered to look at SSc-PAH specifically, and evidence for the use of these medications for SSc-PAH is gathered from subgroup analyses of larger studies or smaller series of SSc patients.
Scleroderma renal crisis is treated with ACE-inhibitors. There is expert agreement that ACE-inhibitor therapy should be maximized in preference to the use of other antihypertensives. There are several retrospective studies that suggest that steroid use greater than 15 mg of prednisone equivalent are associated with a risk for SSc renal crisis, and moderate to high dose steroids should be avoided whenever possible in SSc patients.
Specific scleroderma patients are at higher risk for SRC than others: those with a positive RNA polymerase 3 antibody and those with rapidly progressive early skin involvement. We recommend that these patients, as well as all patients with dcSSc, obtain blood pressure monitors for home use and keep a record of their blood pressure monitoring regularly. We give instructions to notify us if the blood pressure increases by 20-30 points or if it is higher than 140 mm Hg. There is no utility for the prophylactic use of ACE-inhibitors to prevent SRC; however, early treatment of SRC is important to prevent end-stage renal disease, stroke and hypertensive retinopathy.
Scleroderma gastrointestinal disease is an important source of morbidity. Evidence based guidelines for treatment in the form of RCTs are lacking, but proton pump inhibitors should be used for the treatment of gastroesophageal reflux. Promotility agents including Reglan, domperidone and octreotide can be utilized in the treatment of dysmotility, and malabsorption when caused by bacterial overgrowth is treated with antibiotics.
The musculoskeletal manifestations of dcSSc include inflammatory myositis, myopathy related to fibrosis, arthritis, and the development of flexion contractures among others. The treatment of arthritis and inflammatory myositis follows that of other connective tissue diseases. Early and aggressive physical and occupational therapy for the prevention of flexion contractures in scleroderma patients is especially warranted.
Treatment with high-dose corticosteroids early in the course of EF is associated with a beneficial clinical response. The starting dose of corticosteroid is generally prednisone equivalent of 0.5-1mg/kg daily and this should be maintained until there is evidence of clinical response. Subsequent tapering of prednisone is slow and frequently lasts over 1 year. Combination of immunosuppression with MTX or MMF may allow faster tapering of corticosteroid. Use of hydroxychloroquine has also been reported.
Topical therapy with topical steroids or vitamin D analogues, which is frequently effective for other forms of morphea, is usually not sufficient for GM. Phototherapy and/or systemic therapies should be considered. In the case of superficial involvement, a trial of phototherapy, specifically UVA light is prudent. However, if involvement is deep, phototherapy is unlikely to penetrate sufficiently. First line systemic therapy is generally a combination of glucocorticoids and MTX with a target dose of 15-25 mg/weekly by oral or subcutaneous administration. Prednisone 1 mg/kg daily is an appropriate starting dose for patients with rapid progression of disease and deep involvement with a gradual taper. IV pulse methylprednisolone has also been used in severe cases with some efficacy.
Other agents employed for the treatment of morphea include: hydroxychloroquine, MMF, penicillamine, colchicine, cyclosporine, bosentan, and infliximab. There is little evidence to support efficacy for these agents.
What happens to these patients?
SSc is a chronic condition with a heterogeneous clinical course and no curative therapies to date. The prognosis is primarily dependent on internal organ system involvement and disease subtype (limited versus diffuse).
The overall mortality rate of dcSSc is at least fivefold higher than age and sex adjusted general population. ILD and PH are the leading cause of death in scleroderma.
It is important to note that over the past decade, mortality for patients with SSc has significantly improved owing to improved ascertainment of organ system involvement and directed therapy.
Many patients with EF can achieve full remission. Some factors that are associated with poor outcome include younger age of onset, presence of morphea lesions, and truncal involvement. Physical therapy is important to combat the disability associated with flexion contractures.
The clinical course of GM is variable. The plaques can be uncomfortable and disfiguring and can be associated with musculoskeletal complications including arthritis and joint contractures. Morphea lesions in children can be especially disabling when they interfere with normal growth and development. Over time the plaques tend to soften, but pigmentation abnormalities may persist indefinitely.
In SSc, specialty consultations are frequently required including pulmonary (ILD and PH expertise), gastroenterology, dermatology, cardiology, renal, and neurology. The role of the rheumatologist is to determine the organ involvement and refer cases as needed. These are generally not required for GM or EF though coordinated care with Dermatology can take place.
Occupational and Physical Therapy are necessary in the case of SSc, GM and EF. Therapists are essential in the treatment and prevention of contractures which are a large source of disability in this patient population. Referral should be made early, and longer than usual courses of therapy may be of benefit.
Patients with SSc may develop unique dental issues therefore communication between medical doctors and dental providers is essential.
A nutrition referral may be of benefit in patients with issues of malabsorption.
EULAR/EUSTAR recommendations for the treatment of systemic sclerosis were published in 2009 and revised in 2016, and include 14 different recommendations depending on the clinical problem being addressed. In a survey of members of the Scleroderma Clinical Trials Consortium and the Canadian Scleroderma Research Group, most recommendations were relatively well accepted among SSc experts with some regional disagreement based on access differences.
Given the rarity of EF and GM there are no clinical practice guidelines.
M34.9 Systemic sclerosis
M34.1 CREST/Limited scleroderma
L94.0 Morphea/Localized scleroderma
M72.9 Eosinophilic fasciitis
Systemic Sclerosis - diffuse and limited
Hypermobility Syndromes: Marfan's, Ehlers-Danlos
Close more info about Scleroderma and Other Fibrosing Conditions


You can use the extension window to find a certain password you might be looking for.
Go to the Passwords section to start browsing for passwords.
When you find the one you want, click on its name and you'll be redirected to the site with the user credentials pre-populated in the username and password fields.
Alternatively, you can also open a password from within the extension window to copy the credentials manually, if needed.
To open a password, go to the Passwords section, but instead of clicking the name of the password you want, click the cog icon.
This takes you to the password in the extension window.


Many people are familiar with the brand PEAK as they see it when shopping for automotive fluids. They may even prefer this brand for engine coolant if their vehicle requires adding a little from time. When it comes to a Diesel Truck DEF products are required, and consumers who have always relied on their favorite engine coolant will be glad to know they can buy diesel exhaust fluid in that brand as well.
Fleet managers also must make sure that their vehicles have sufficient Diesel Truck DEF at all times. The drivers receive dashboard alerts when the fluid in the container drops to a certain level. They then can refill it the next time they reach a service station. Fleet managers may encourage their drivers to fill the container whenever they add diesel fuel to the tank, as that's most convenient and prevents the risk of running out.
Drivers who have no experience in driving diesel-powered vehicles or in adding DEF must receive some instruction about the exhaust fluid. As with gas-powered automobiles, adding diesel fuel is straightforward because it goes in the fuel tank. DEF does not, however. It goes in a separate container. At service stations, the nozzle for diesel fuel should not fit into the opening for the DEF container. That prevents contamination of diesel with DEF, a product that is meant to go directly into the exhaust system.
Someone might wonder whether this actually would be such a big problem, but they can consider all the other fluids that cannot be mixed without the risk of damaging the vehicle. Engine oil lubricates the motor, for instance, and coolant keeps the motor from overheating. Yet these two fluids cannot be combined in the same container.
If the fleet drivers are not traveling to distant locations, the addition of DEF may be part of routine vehicle maintenance back at the company's location. Each fleet manager has his or her own system. The main points in regard to this particular fluid are making sure it never runs out and that it is not added to the fuel tank.


text:
THE KILLERS (1946)
1946, Universal, 103 min, USA, Dir: Robert Siodmak
The CITIZEN KANE of film noir that begins with the ending - "I did something wrong ... once" - and moves backward through interweaving flashbacks to reveal the layer of double crosses that led to the opening scene. The script by Anthony Veiller (with an uncredited assist from John Huston) takes the first 10 minutes from Hemingway's short story and then spirals into the noir netherworld that Robert Siodmak depicted better than any other director. The smoldering sexuality between Burt Lancaster and Ava Gardner catapulted both to super-stardom. With Edmond O'Brien and Jeff Corey.
Mark Hellinger
Anthony Veiller
Elwood Bredell
1939, Warner Bros., 106 min, USA, Dir: Raoul Walsh
Raoul Walsh burst onto the screen in his first Warner Bros. directorial outing with this sensational gangster tale starring James Cagney and Humphrey Bogart as World War I vets who return to an unwelcoming American society and head straight for the criminal life in a world of bootlegging and shady nightclubs. With a script from crackerjack Warner Bros. writing team Jerry Wald and Richard Macauley, and produced by the incorrigible erstwhile journalist Mark Hellinger, this picture bristles with suspense, smart-aleck humor and Walsh's great comic and dramatic timing. The triple threat of Cagney, Bogey and Walsh make for nonstop action and fun. A terrific round-up and look-back at the great Warner Bros. gangster yarns of the 1930s, this film says it all about how the studio kept in touch with the hard-knock life of the times. Also starring the inimitable Gladys George as Cagney's saloon-owning friend and Pricilla Lane as the woman who just can't love Cagney the way he wants. A blast of energy that is pure Walsh!
Jerry Wald
Richard Macauley
Gladys George
1947, Universal [Upcoast Film Consultants], 98 min, USA, Dir: Jules Dassin
Intense, violent and nihilistic in the extreme, this Mark Hellinger-produced prison drama may well be the bleakest, most despairing film noir of them all. Burt Lancaster plots a breakout for the inmates of Cell R-17 so they can escape the sadism of fascistic bully Hume Cronyn. The climactic bust-out remains a shocker, as the escape erupts into full-throttle warfare. Still the most unforgettable men-behind-bars movie ever made! "Men caged on the inside… Driven by the thought of their women on the loose!"
Hume Cronyn

redpajama_set_name: RedPajamaCommonCrawl


r.r. equipment company. home; rebel crusher; machines. vibrating grizzly feeders; crushers. jaw crushers; impact crushers; cone crushers; screens.
crush all® is an impact or jaw crusher in a bucket. regardless, we provide all the necessary schematic diagrams you will need to plumb your machine if required.


It looks like Schoology is attempting (or about to attempt) to get some data from that Google Drive – there's a good chance Shields is blocking the action here. Turn Shields down (temporarily) and try performing the action again. If it works, we know Shields is at pay here – from there you can narrow down the individual protection causing issues.


text:
Holder Steps Forward For Shorter Drug Sentences
ROBERT SIEGEL, BYLINE: Senior Justice Department lawyers pledge their support today for a plan that would reduce prison sentences for most people convicted of federal drug crimes. Attorney General Eric Holder told the U.S. Sentencing Commission that he backs the proposal that could cut prison terms for thousands of convicts and save billions of dollars of over time. NPR's Carrie Johnson has the story.
CARRIE JOHNSON, BYLINE: The country's top law enforcement officer says there's a way to save money and keep crime rates low by being smarter about the Justice Department approach to drug offenses.
ERIC HOLDER: By reserving the most severe penalties for dangerous and violent drug traffickers, we can better promote public safety, deterrence and rehabilitation while saving billions of dollars and strengthening communities.
JOHNSON: Eric Holder offered his approval for plans by the U.S. Sentencing Commission that would shave about a year off the sentences of most people convicted of drug crimes, a step that could drop the U.S. prison population by more than 6,000 inmates over the next five years.
HOLDER: We are not retreating from a strong, tough fight against those who would engage in drug trafficking and in violence. What we're talking about is a better approach so that we can keep this country and Mexico more safe.
JOHNSON: Judge Patti Saris chairs the Sentencing Commission, which is evaluating a broad range of criminal justice penalties.
JUDGE PATTI SARIS: Since drug offenders make up the majority of the federal prison populations, drug sentences were a logical place to start.
JOHNSON: Jeremy Haile works at The Sentencing Project, which advocates for reform of drug laws.
JEREMY HAILE: This amendment proposed today is a necessary but an insufficient step.
JOHNSON: Haile says that's because the justice system is so overloaded that it needs a major overhaul.
HAILE: So we need Congress to act to address mandatory minimum penalties. That's the only long-term means of reducing excessive incarceration.
JOHNSON: Bipartisan plans to give judges more discretion and for early release of nonviolent inmates have won support in the Senate Judiciary Committee this year. But efforts in the U.S. House have been a bit slower to develop, and not all prosecutors are on board with these changes.
The National District Attorneys Association says the vast majority of people in federal prison have been, quote, "very bad actors for a long time." The district attorneys say tough penalties for drug crimes help the government get cooperation and make cases against kingpins, and giving felons lighter sentences isn't fair to crime victims and communities that have been devastated by drugs. The Sentencing Commission will hold a vote on the plans next month.
Carrie Johnson, NPR News, Washington. Transcript provided by NPR, Copyright NPR.


Savings with Crabtree & Evelyn promo codes and coupon codes for April 2019. Today's top Crabtree & Evelyn coupon: Sample Sale! Up to 70% Off Final Sale Products.
Updated the best Crabtree & Evelyn coupons, coupon codes and promo codes for April 2019. You can find the best Crabtree & Evelyn promo codes and Crabtree & Evelyn coupon codes in April 2019 for savings money when shoping at online store Crabtree & Evelyn.
Ends: 05/22/19 Details: No coupon code needed. Tap to shop the sale now.
Expires: 04/22/19 Details: Get a Free 25g hand therapy for $60 or more, A 100ml hand therapy for $80 or more, or A 250ml hand therapy for $100.
Expires: 02/28/19 Details: Get a Free 25g hand therapy on orders over $60 or 100ml hand therapy on orders over $80 or 250ml hand therapy on orders over $100.


text:
Fracked Liquefied Natural Gas (LNG) Exports Were Centerpiece in Panama Canal Expansion
Documents Reveal
By Steve Horn
Desmog 29 June 2016
Theme: Environment, Global Economy, Oil and Energy
In-depth Report: Climate Change
After nearly a decade of engineering work on the project, the Panama Canal's expansion opened for business on June 26.
At the center of that business, a DeSmog investigation has demonstrated, is a fast-track export lane for gas obtained via hydraulic fracturing ("fracking") in the United States. The expanded Canal in both depth and width equates to a shortened voyage to Asia and also means the vast majority of liquefied natural gas (LNG) tankers — 9-percent before versus 88-percent now — can now fit through it.
Emails and documents obtained under open records law show that LNG exports have, for the past several years, served as a centerpiece for promotion of the Canal's expansion by the U.S. Gulf of Mexico-based Port of Lake Charles.
And the oil and gas industry, while awaiting the Canal expansion project's completion, lobbied for and achieved passage of a federal bill that expanded the water depth of a key Gulf-based port set to feed the fracked gas export boom.
Control of the Panama Canal by U.S. big business and Wall Street has, for over a century, served as a focal point of U.S. foreign policy in the Americas.
While no longer in de facto control of the isthmus as it was during the days of the Panama Canal Zone, Jill Biden's presence as part of an official Presidential Delegation at the expanded Canal's opening ceremony symbolized the importance of the waterway and de jure role of the U.S. government in pushing for its expansion over the past several years. So too did the attendance of the U.S. military's Southern Command (SOUTHCOM).
And in turn, the reported participation of LNG exports giant Cheniere Energy at the kick-off serves as a portrayal of the importance of the Canal's expansion to the oil and gas industry. The Panama Canal Authority estimates that 20 million tons of LNG may pass through on an annual basis.
"The volume projected by the Panama Canal Authority represents about 8 percent of global LNG trade and is equivalent to nearly 300 ships a year," Bloomberg explained.
In a press release announcing the Canal expansion's opening, LNG shipments receive a prominent mention.
"We are thrilled that we currently have 170 reservations for Neopanamax ships, commitments of two new liner services to the Expanded Canal, and a reservation for the first LNG vessel, which will transit in late July," Jorge Quijano, CEO of the Panama Canal Authority, stated in the release. "Our customers care that their supply chain is reliable and that they have a diversity of shipping options. And the Canal has always been reliable; today, we offer the world new shipping options and trade routes."
It has taken a rigorous lobbying and influence peddling effort by the oil and gas industry to make the looming first LNGshipment through the Canal a reality.
Lake Charles LNG MOUs
In January 2015, Port of Lake Charles officials signed a memorandum of understanding (MOU) with Panama Canal Authority officials.
The MOU explicitly mentions the role the Canal could play in opening up the global spigot for LNG exports and a fast-lane to Asia. A sign of the importance of the Canal's expansion to Asia, the Japan Bank for International Corporation signed a loan agreement with the Panama Canal Authority in December 2008 for $800 million. Japan, in the aftermath of the Fukushima nuclear disaster, has shifted its energy portfolio in the direction of increased reliance on natural gas and LNG imports.
Image Credit: Port of Lake Charles
Officials involved with the effort signed the MOU at the Louisiana-based Port of Lake Charles in an event that featured invitations sent out to executives of the seven Lake Charles-based LNG companies. In the aftermath of signing the MOU, Quijano held a meeting with the LNG company representatives present at the ceremony.
The Port of Lake Charles houses the approved Sempra LNG facility and the proposed Trunkline LNG and Magnolia LNG facilities.
Matt Young — then the public relations director for the O'Carroll Group public relations firm and current public information officer for the City of Lake Charles — wrote the talking points for the MOU ceremony for Port of Lake Charles officials. At the time and as of April, O'Carroll oversaw the public relations and marketing work for the Magnolia LNG.
Industry Lobbies to Re-engineer Sabine
Beyond the MOU with Lake Charles, the oil and gas industry also used its lobbying prowess to win federal tax dollars that would go toward deepening and re-engineering ports and key coastal waterways in service to industrial interests such as LNGexports. They did so via the Water Resources Reform and Development Act of 2014 (H.R. 3080).
Those lobbying for H.R. 3080 included the likes of LNG trader Koch Industries, LNG industry giant BG Group (now owned by Shell), Sempra Energy (owner of the Lake Charles-based Sempra LNG facility), Independent Petroleum Association of America(IPAA), American Petroleum Institute (API), BP America and ExxonMobil.
BP, Bloomberg has reported, is set to send the first LNG tanker through the Panama Canal in July.
The bill "includes the deepening of the Sabine-Neches Waterway to 48 feet from its current 40 feet. The entire bill is for 34 projects across the country with a price tag of $12 billion," explained the Beaumont Enterprise. "The Sabine-Neches project, listed first in the bill, would be funded at $748 million and is 75 percent of the project cost."
Sabine-Neches connects to Cheniere's Sabine Pass LNG facility, ExxonMobil's proposed Golden Pass LNG facility and Sempra's LNG facility. According to the Sabine-Neches Navigation District website, the Waterway is "projected to become the largest LNGexporter in the United States."
In a PowerPoint presentation from August 2012, the Sabine-Neches Navigation District boasted that it could soon become "Texas' first Panama Canal ready Port."
Image Credit: Sabine-Neches Navigation District
A May 2014 article published by Bloomberg overtly links the bill's passage with the expansion of both the Panama Canal and the Sabine-Neches Waterway.
"House and Senate negotiators reached agreement on a bill that would authorise deepening several US ports ahead of the expansion of the Panama Canal and the bigger ships that will use it," reads the article. "The Port Arthur area is home to the southern end of the Keystone XL pipeline. Deepening the port will reduce shipping costs for oil and natural gas processed there by Exxon Mobil, Total and Cheniere Energy."
BG Group, which lobbied for the port expansion legislation, said in its quarter four 2010 investor call that the opening of the Panama Canal means more trade and business opportunities for the company.
In a July 2015 article published in Platts, a Panama Canal Authority official stated that he expects relatively little LNG export-centric traffic in the Canal through about 2020, as Gulf of Mexico-based terminals await approval by the U.S. Department of Energy (DOE) and U.S. Federal Energy Regulatory Commission (FERC).
"The first two years of operations [after the 2016 expansion] we expect few transits per year because only one export terminal from the Gulf of Mexico will be operational," the Canal official told Platts. "As more terminals come online, traffic of LNGcarriers should pick up after 2016…until reaching around three transits per day after 2020."
Oscar Bazán, the Panama Canal's executive vice president for planning and development, recently told The Wall Street Journal that by 2020, LNG tankers could be the main cargo sailing through the Canal.
Like the story of the Panama Canal's expansion and the myriad LNG tankers which soon may pass through it, the Canal's origins tie back to lobbying and the realization of corporate and Wall Street interests. This was noted in a 1903 editorial penned by The New York Times.
"In order rightly to understand what we are doing we must acknowledge to ourselves that this territory through which we are to build the canal is stolen property, that our partners in the theft are a group of canal promoters and speculators and lobbyists," opined The Times, proceeding to write that whether the U.S. goes through with the deal or not "the world will get a true measure of the American conscience."
Given the life-cycle greenhouse gas impacts of fracking and shipping LNG across the planet for climate change in today's context, it could reasonably be argued that what the U.S. and industry are doing this time around is unconscionable.
The original source of this article is Desmog
Copyright © Steve Horn, Desmog, 2016
Articles by: Steve Horn


text:
Isbill är ett verktyg för att slå hål i is, eller för att undersöka isens tjocklek.

Både isbillar och ispikar av äldre modell har träskaft med en underdel av stål. Ispikar har ett långt träskaft och en kort stålspets, medan isbillar har ett kort eller halvkort skaft och en längre spettliknande underdel av stål. Moderna ispikar för främst långfärdsskridskoåkning är ofta gjorda i helmetall, i aluminium.

Isbillens användning är i första hand att slå hål i isen, till exempel vid angelfiske, medan ispiken främst används för att mäta isens bärighet.

Källor
Om ispikar på Linköpings långfärdsskridskoklubbs webbplats, läst 2011-06-14

Verktyg

redpajama_set_name: RedPajamaWikipedia


Isoscan is an Insulation Fault locating device.
Ring main unit (RMU) available up to 33 Kv.
Complete solution for Relaying with different series (Micom, Vamp, SEPAM) .
Available range 10 to 15 MVA.
Instrument transformer up to 400 kV.
Ladder, Mesh & Perforated type.
Range 0.5A to 125 A with different pole configuration.
Variable Frequency Drives (VFD) –Available range up to 2000 HP.
Up to 1600A (AC & DC) with microprocessor based protection.
Available range 10 to 300 kVA.
Isometer is an Insulation Monitoring Device.
Flair is a Fault Passage Indicator.
Sleeves up to 400 KV.
Jointing & Termination Kits up to132 kV.
Sarthak Components Pvt. Ltd. is an innovation company that never stops inventing. We deploy world-class science and engineering to seize market opportunities and solve some of the biggest challenges of our customers. Over last few years, our innovative ideas have improved systems and processes of many industries, utilities, buildings and infrastructure.
Earn the admiration of all those associated with us.
OEM Tapes & Insulation paper Solutions.
RCBO (RCD + MCB) Type PKNM.
Earthing System and Surge Protection Devices.
"SARTHAK COMPONENTS is a very Good Vendor. would like to work with them again and again.Had pleasing experience"
"SARTHAK COMPONENTS is excellent service provider. Completely satisfied with the services provided by company. Looking forward for more works. "
"Very Happy with the Service provided by SARTHAK COMPONENTS. Wish to work with SARTHAK again. Very competitive and competent service"


Ruffles Lodge & Spa is an exclusive Hinterland wedding experience. The private 12-villa retreat has a variety of accommodation packages for your family and friends to stay over-night to continue the celebrations. From an intimate ceremony to an lavish event, the retreat offers a range of all-inclusive wedding packages including your choice of three elegant and charming ceremony locations, surrounded by the beauty of nature.
Discover the perfect setting for your wedding day at the hilltop haven of Ruffles Lodge. Your unique choices include the Observation Deck with 180 degree views of the Gold Coast; under the Gazebo beside the infinity pool (a perfect wet weather option), or in the Terrace Room with breathtaking views of the Gold Coast.


Witch Hair began in Spring 2015 with a simple text message "What about the name Witch Hair?" from Joe Russo (guitar, vocals) to Ashley Kenney (bass, vocals.) After their bands played together at the Heirloom Arts Theater in August of 2014, Joe and Ashley felt an immediate bond. They knew they had to form a project where they could write and sing collaboratively and explore different musical avenues than they had in their current acts (Spectral Fangs, and Loom respectively). They truly met their musical match in the Fall of 2016 when Tom Connolly (drums, vocals) moved back from Philadelphia to Connecticut having played in several Philly bands including Forbidden Rooms, Ladies Auxiliary, Killer Bangs, and Tin Horses.
For a band that started by jamming on Breeders and Pixies covers it was an honor that their first show was opening for Kelley Deal (of the Breeders) and her band R. Ring at BAR in New Haven. The trio has continued a streak of playing with nationally lauded acts such as Charly Bliss, Laser Background, XETAS, and Lola Pistola ever since. The group has written songs about motorcycle gangs, cults, and activism, and they have hosted two very successful fundraisers for Planned Parenthood and the Connecticut Institute for Refugees and Immigrants. Always wearing their hearts on their sleeves, Witch Hair plans to continue writing songs about the current declining state of American Affairs with brutal honesty.


text:
Q: How to use angular2 with paperjs? I am new to angular 2 and I would like to understand how I should install the paperjs library in my angular2 client. Should I just type npm install paper? This doesn't seem to include paperjs in my app. Should I just include it using the <script> tag? Please help me understand how I should approach this problem.

A: this question was answered before here
I did the following to get it working:
npm install paper --save
npm install @types/paper --save

In systemjs.comfig.js add a map for paper
map:
    ...

    'paper': 'npm:paper/dist/paper-core.js'
},

In the component
import { PaperScope, Path, Point } from 'paper';

Note for Ionic2 users: You can skip the systemjs.config.js part.

redpajama_set_name: RedPajamaStackExchange


text:
What companies make small planes?
Top 10 Private Aircraft Manufacturers
Airbus Corporate Jets. Company Overview.
Boeing Business Jet. Aircraft Models.
Bombardier Business Aircraft (BBA) Aircraft Models.
Beechcraft.
Cessna.
Dassault Aviation.
Embraer.
Gulfstream Aerospace.
What is the smallest jet made?
Bede BD-5J Microjet
The smallest jet aircraft is the home-built Bede BD-5J Microjet owned by Juan Jimenez of San Juan, Puerto Rico, USA, which weighs 162 kg (358 lb), is 3.7 m (12 ft) long, has a 5.7 m (17 ft) wingspan, and can fly at 483 km/h (300 mph).
What is the best private jet manufacturer?
The World's Leading Private Jets Manufacturers
Bombardier. Bombardier Aviation is a Canadian aircraft manufacturer based in Doval, Quebac, and a subsidiary of the Bombardier Inc group.
Dassault.
Gulfstream.
Honda.
Nextant.
Why are there only 2 airplane manufacturers?
Two main factors are the reason who Airbus and Boeing's dominance over the airplane manufacturing industry: money and history. With both of these factors on their side, Airbus and Boeing can easily maintain their positions as the top companies. Manufacturing airplanes requires significant costs.
What is the most reliable small aircraft?
7 Best Single-Engine Airplanes to Own Right Now
Diamond DA40 NG. When it comes to safety, the DA40 NG (the "NG" stands for "next generation") is just about the best single-engine plane to own.
Beechcraft G36 Bonanza.
Cessna 172.
Mooney M20 Acclaim Ultra.
Pilatus PC-12 NG.
Piper M350.
Cirrus SR22T.
Which is the smallest private jet?
The Cirrus SF50 Vision Jet Is the World's Smallest And Most Affordable Private Jet
The private jet industry is highly competitive, one in which companies will utilize any advantage to maintain existing clients while also luring in new ones.
Cirrus's SF50 Vision Jet cost $1.96 million.
What's the cheapest private jet you can buy?
Cirrus Vision Jet
This is the cheapest private jet in the world — and it's a true game changer. The Airbus A380 superjumbo may be the next big thing in private jets, but the tiny Cirrus Vision Jet is the next game changer. At $1.96 million, the diminutive Cirrus is the most affordable private jet on sale today.
What is the cheapest private plane to buy?
The Cirrus Vision Jet is the cheapest private jet money can buy at $1.96 million. The Vision Jet is easy to fly and even has a parachute for the entire plane if things go really wrong.
Who is the largest aircraft manufacturer in the world?
The Boeing Company is the largest aerospace company in the world, with its heritage mirroring the history of aviation. It is the world's largest manufacturer of commercial jetliners, military aircraft and the nation's largest NASA contractor.
Who are the major airplane manufacturing companies?
– Boeing. Boeing is not only the most popular aerospace company in the world but also the largest by revenue at US$93.4 billion in 2017. – Airbus. Airbus has a vast interest and investment in the commercial and military aerospace market. – Lockheed Martin. – United Technologies. – GE Aviation.
What are the biggest airplane companies?
American Airlines Group is the largest by its fleet size, revenue, passengers carried and revenue passenger mile. Delta Air Lines is the largest by assets value and market capitalization, while Southwest Airlines leads by profit.


11. The skidding away of the vehicle on a level circular path can be avoided if the force of friction between the wheels and the ground is __________ the centrifugal force.
14. Which of the following is the example of lever of first order?


text:
Grasscut — Catholic Architecture
(Ninja Tune , 2014, CD)
by Henry Schneider, Published 2014-10-25
Grasscut is the Brit duo of composer / vocalist / musician Andrew Phillips and manager / musician Marcus O'Dair. Phillips writes and produces all of the music and he is also known for his soundtracks for HBO, BBC Films, and Channel 4. O'Dair contributes keyboards and double bass and he is also a writer of Robert Wyatt's authorized biography that will be published by Serpent's Tail later this month. Grasscut have released two albums, with their third coming in 2015. In the past they have worked with Robert Wyatt, John Surman, the Kronos Quintet, Gazelle Twin, Seb Rochford of Polar Bear, and members of the Elysian Quartet. In anticipation of their third album, Everyone Was a Bird, Grasscut decided to release a new AA single this fall. The two songs on this single are a cover of Robert Wyatt's "Catholic Architecture" from Dondestan and "Beacon," an original composition. Robert Wyatt has been a significant influence on the band and their cover of "Catholic Architecture" is an improvement on the original. It is eerie and almost childlike in Phillips' orchestration. There is a definite Canterbury vibe here along with some very tasteful trumpet soloing that provides a jazzy aspect absent from Wyatt's performance. "Beacon" continues in the same vein with some breathy vocals and its dark, almost Gothic, mood. Over the song's four and a half minutes the music transforms from its dark electronics to live violin/fiddle and drums and builds to a wonderful climax, to presage the sound of their upcoming 2015 album.
Filed under: New releases, 2014 releases
Related artist(s): Robert Wyatt, Grasscut
Änglagård - Gånglåt från Knapptibble – The long-awaited new Änglagård single has finally hit the shelves as part of the latest Ptolemaic Terrascope magazine. In each issue (a grass-roots psychedelic/underground offering published in the... (1994) » Read more
Ziggy really surfed, screwed up eyes and screwed down hair-do


Madison-Burns & Associates, LLC solutions may be delivered in group workshops, at your annual sales conference, in one-on-one sessions with key managers, through meeting facilitation, or even via today's distance-learning technologies. Recognizing that how people learn new skills is just as important as what they learn, we will work with you to identify the most effective and efficient learning vehicles for achieving change within your culture and budget.
If you tend to be rushed all day - try building a margin time. Schedule an extra 10 minutes between activities.
Our solutions will draw from a content bank of skills and knowledge that have proved critical to achieving performance breakthroughs. Tailored to your environment and business processes, the resulting interactive learning experiences will produce on-the-job results. Equally important, to ensure that initiative's lasting results, we'll work with you to incorporate reinforcement mechanisms that ensure continuous improvement and to identify measurement tools that track progress.


text:
package com.bolyartech.forge.server.modules.user.endpoints;

import com.bolyartech.forge.server.db.DbPool;
import com.bolyartech.forge.server.misc.Params;
import com.bolyartech.forge.server.modules.user.ForgeUserDbEndpoint;
import com.bolyartech.forge.server.modules.user.UserResponseCodes;
import com.bolyartech.forge.server.modules.user.data.User;
import com.bolyartech.forge.server.modules.user.data.UserDbh;
import com.bolyartech.forge.server.modules.user.data.scram.ScramDbh;
import com.bolyartech.forge.server.modules.user.data.scram.UserScramUtils;
import com.bolyartech.forge.server.modules.user.data.screen_name.ScreenName;
import com.bolyartech.forge.server.modules.user.data.screen_name.ScreenNameDbh;
import com.bolyartech.forge.server.modules.user.data.user_scram.UserScramDbh;
import com.bolyartech.forge.server.response.ResponseException;
import com.bolyartech.forge.server.response.forge.ForgeResponse;
import com.bolyartech.forge.server.response.forge.MissingParametersResponse;
import com.bolyartech.forge.server.response.forge.OkResponse;
import com.bolyartech.forge.server.route.RequestContext;
import com.bolyartech.forge.server.session.Session;
import com.bolyartech.scram_sasl.common.ScramUtils;
import com.google.common.base.Strings;
import com.google.gson.Gson;

import java.sql.Connection;
import java.sql.SQLException;

public class RegistrationPostAutoEp extends ForgeUserDbEndpoint {
    static final String PARAM_NEW_USERNAME = "new_username";
    static final String PARAM_NEW_PASSWORD = "new_password";
    static final String PARAM_SCREEN_NAME = "screen_name";

    private final Gson mGson;

    private final UserDbh mUserDbh;
    private final ScramDbh mScramDbh;
    private final UserScramDbh mUserScramDbh;
    private final ScreenNameDbh mScreenNameDbh;

    public RegistrationPostAutoEp(DbPool dbPool,
                                  UserDbh userDbh,
                                  ScramDbh scramDbh,
                                  UserScramDbh userScramDbh,
                                  ScreenNameDbh screenNameDbh) {

        super(dbPool);
        mGson = new Gson();
        mUserDbh = userDbh;
        mScramDbh = scramDbh;
        mUserScramDbh = userScramDbh;
        mScreenNameDbh = screenNameDbh;
    }

    @Override
    public ForgeResponse handle(RequestContext ctx,
                                Session session,
                                Connection dbc,
                                User user) throws ResponseException, SQLException {

        String newUsername = ctx.getFromPost(PARAM_NEW_USERNAME);
        String newPassword = ctx.getFromPost(PARAM_NEW_PASSWORD);
        String screenName = ctx.getFromPost(PARAM_SCREEN_NAME);

        if (!Params.areAllPresent(newUsername, newPassword)) {
            return MissingParametersResponse.getInstance();
        }

        ScreenName existingScreenName = mScreenNameDbh.loadByUser(dbc, user.getId());
        if (existingScreenName == null) {
            if (Strings.isNullOrEmpty(screenName)) {
                return new MissingParametersResponse("missing screen name");
            } else if (!ScreenName.isValid(screenName)) {
                return new ForgeResponse(UserResponseCodes.Errors.INVALID_SCREEN_NAME, "Invalid screen name");
            }
        }

        if (!User.isValidUsername(newUsername)) {
            return new ForgeResponse(UserResponseCodes.Errors.INVALID_USERNAME, "Invalid username");
        }

        if (!User.isValidPasswordLength(newPassword)) {
            return new ForgeResponse(UserResponseCodes.Errors.INVALID_PASSWORD, "Password too short");
        }

        ScramUtils.NewPasswordStringData data = UserScramUtils.createPasswordData(newPassword);

        boolean rez;
        if (existingScreenName == null) {
            rez = mUserScramDbh.replaceExisting(dbc, mScramDbh, mScreenNameDbh,
                    user.getId(), newUsername, data, screenName);
        } else {
            mUserScramDbh.replaceExistingNamed(dbc, mScramDbh,
                    user.getId(), newUsername, data);
            rez = true;
        }

        if (rez) {
            return new OkResponse();
        } else {
            return new ForgeResponse(UserResponseCodes.Errors.SCREEN_NAME_EXISTS, "Scree name already taken");
        }
    }

}

redpajama_set_name: RedPajamaGithub


text:
package com.github.fge.grappa.transform.process;

import com.google.common.collect.ImmutableList;
import com.github.fge.grappa.transform.TestParser;
import org.testng.annotations.BeforeClass;
import org.testng.annotations.Test;

import java.io.IOException;
import java.util.List;

import static com.github.fge.grappa.transform.AsmTestUtils.assertTraceDumpEquality;

public class ReturnInstructionUnifierTest extends TransformationTest {

    private final List<RuleMethodProcessor> processors = ImmutableList.of(
            new UnusedLabelsRemover(),
            new ReturnInstructionUnifier()
    );

    @BeforeClass
    public void setup() throws IOException {
        setup(TestParser.class);
    }

    @SuppressWarnings("unchecked")
    @Test
    public void testReturnInstructionUnification() throws Exception {
        assertTraceDumpEquality(processMethod("RuleWithSwitchAndAction", processors), "" +
                "    ILOAD 1\n" +
                "    LOOKUPSWITCH\n" +
                "      0: L0\n" +
                "      default: L1\n" +
                "   L0\n" +
                "    ALOAD 0\n" +
                "    GETSTATIC com/github/fge/grappa/transform/TestParser.EMPTY : Lcom/github/fge/grappa/rules/Rule;\n" +
                "    ALOAD 0\n" +
                "    ICONST_1\n" +
                "    INVOKESTATIC java/lang/Integer.valueOf (I)Ljava/lang/Integer;\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.push (Ljava/lang/Object;)Z\n" +
                "    INVOKESTATIC java/lang/Boolean.valueOf (Z)Ljava/lang/Boolean;\n" +
                "    ICONST_0\n" +
                "    ANEWARRAY java/lang/Object\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.sequence (Ljava/lang/Object;Ljava/lang/Object;[Ljava/lang/Object;)Lcom/github/fge/grappa/rules/Rule;\n" +
                "    GOTO L2\n" +
                "   L1\n" +
                "    ACONST_NULL\n" +
                "   L2\n" +
                "    ARETURN\n");

        assertTraceDumpEquality(processMethod("RuleWith2Returns", processors), "" +
                "    ILOAD 1\n" +
                "    ALOAD 0\n" +
                "    GETFIELD com/github/fge/grappa/transform/TestParser.integer : I\n" +
                "    IF_ICMPNE L0\n" +
                "    ALOAD 0\n" +
                "    BIPUSH 97\n" +
                "    INVOKESTATIC java/lang/Character.valueOf (C)Ljava/lang/Character;\n" +
                "    ALOAD 0\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.action ()Z\n" +
                "    INVOKESTATIC com/github/fge/grappa/transform/TestParser.ACTION (Z)Lcom/github/fge/grappa/rules/Action;\n" +
                "    ICONST_0\n" +
                "    ANEWARRAY java/lang/Object\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.sequence (Ljava/lang/Object;Ljava/lang/Object;[Ljava/lang/Object;)Lcom/github/fge/grappa/rules/Rule;\n" +
                "    GOTO L1\n" +
                "   L0\n" +
                "    ALOAD 0\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.eof ()Lcom/github/fge/grappa/rules/Rule;\n" +
                "   L1\n" +
                "    ARETURN\n");

        assertTraceDumpEquality(processMethod("RuleWithDirectExplicitAction", processors), "" +
                "    ALOAD 0\n" +
                "    BIPUSH 97\n" +
                "    INVOKESTATIC java/lang/Character.valueOf (C)Ljava/lang/Character;\n" +
                "    ALOAD 0\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.action ()Z\n" +
                "    IFEQ L0\n" +
                "    ALOAD 0\n" +
                "    GETFIELD com/github/fge/grappa/transform/TestParser.integer : I\n" +
                "    IFLE L0\n" +
                "    ICONST_1\n" +
                "    GOTO L1\n" +
                "   L0\n" +
                "    ICONST_0\n" +
                "   L1\n" +
                "    INVOKESTATIC com/github/fge/grappa/transform/TestParser.ACTION (Z)Lcom/github/fge/grappa/rules/Action;\n" +
                "    ICONST_1\n" +
                "    ANEWARRAY java/lang/Object\n" +
                "    DUP\n" +
                "    ICONST_0\n" +
                "    BIPUSH 98\n" +
                "    INVOKESTATIC java/lang/Character.valueOf (C)Ljava/lang/Character;\n" +
                "    AASTORE\n" +
                "    INVOKEVIRTUAL com/github/fge/grappa/transform/TestParser.sequence (Ljava/lang/Object;Ljava/lang/Object;[Ljava/lang/Object;)Lcom/github/fge/grappa/rules/Rule;\n" +
                "    ARETURN\n");
    }

}


text:
KACO new energy ist ein Hersteller von Stromrichtern, insbesondere Wechselrichter und Monitoring-Zubehör für Photovoltaikanlagen sowie Stromversorgungen für industrielle Bereiche. Das Unternehmen mit Sitz in Neckarsulm, Baden-Württemberg, gehört zu den Wegbereitern der trafolosen Wechselrichtertechnik, die sich wegen ihres hohen Wirkungsgrades zum Standard entwickelt hat. KACO hat von 1999 bis ca. 2009 Wechselrichter mit einer kumulierten Leistung von 3 Gigawatt ausgeliefert und war 2009 der zweitgrößte Hersteller nach verkaufter Wechselrichterleistung. Mit Wirkung vom 30. April 2019 hat die Siemens AG 100 Prozent der Anteile übernommen.

Geschichte
Das Unternehmen wurde im Jahre 1999 unter dem Namen KACO Gerätetechnik GmbH aus dem im Heilbronner Stadtteil Sontheim ansässigen und kurz danach geschlossenen Unternehmen KACO Elektrotechnik heraus gegründet. Schon in den 1950er-Jahren war das Unternehmen KACO, aus dem 1970 die spätere KACO Elektrotechnik hervorging, weltgrößter Lieferant für elektromechanische Zerhacker, die Vorfahren der heutigen Wechselrichter. Im Jahr der Ausgründung 1999 brachte KACO Gerätetechnik einen der ersten trafolosen Serienwechselrichter auf den Markt.

2003 verlegte das Unternehmen den Sitz von Heilbronn nach Neckarsulm, wo innerhalb von vier Jahren drei neue Werke entstanden. 2009 erfolgte die Umfirmierung in KACO new energy GmbH, das Unternehmen bezog eine neue Zentrale.
2010 begann der Ausbau der Fertigungskapazitäten auf 10 Gigawatt, Aufteilung der Produktionsstandorte auf Deutschland für den europäischen Markt, USA für den amerikanischen Kontinent sowie Korea für Asien. Es erfolgte die Gründung der Tochterfirmen in Frankreich und Italien.
2011 nehmen die neuen Werke in Neckarsulm und London/Ontario (Kanada) die Produktion auf. Ebenso startet die Produktion in San Jose/Kalifornien (USA).

Im Jahr 2016 wurde der Abbau von 80 Arbeitsplätzen am Standort Neckarsulm bekannt gegeben.

Die KACO new energy wurde 2019 durch die Siemens AG übernommen, sie firmiert seither als "KACO new energy GmbH – A Siemens Company" mit Sitz in Neckarsulm.

Unternehmensstruktur

Am Stammsitz in Neckarsulm sowie im benachbarten Erlenbach verfügte KACO new energy 2011 aktuell (Stand Juli 2011) über fünf Werke: In Werk 1 ist die Unternehmenszentrale und die Produktion von Zentralwechselrichtern untergebracht. Werk 2 fungiert als Service-Center. In Werk 3 werden alle Stringwechselrichter produziert. Im Werk 4 am Standort Neckarsulm werden Komponenten für den Bahn- und Automotivebereich entwickelt und produziert.

Forschung und Entwicklung sind auf verschiedene Standorte verteilt: Jeweils ein Team in Neckarsulm und in Kassel arbeitet an der Entwicklung aller Geräte in den Leistungsklassen unterhalb 100 Kilowatt. Ein Team in Seongnam in Südkorea entwickelt Wechselrichter in den Leistungsklassen darüber.

KACO new energy operiert mit derzeit 12 Tochtergesellschaften in den USA, Südkorea, China, den Vereinigten Arabischen Emiraten, der Türkei, Südafrika, Frankreich und Italien. Über Niederlassungen ist KACO ebenfalls in Großbritannien, Kanada, Indien und in Jordanien vertreten.

Produkte
Das Produktangebot umfasst unter anderem
 Solarwechselrichter
 Wechselrichter für Blockheizkraftwerke und Brennstoffzellen
 Stromversorgungen für Schienenfahrzeuge und Industrie

Soziales und politisches Engagement
Mit Geldspenden hat das Unternehmen verschiedene soziale Projekte unterstützt. Ein Beispiel ist die karitative Stiftung Große Hilfe für kleine Helden.

Einzelnachweise

Photovoltaikhersteller (Deutschland)
Elektrotechnikhersteller
Unternehmen (Neckarsulm)
Leistungselektronik
Gegründet 1999
Produzierendes Unternehmen (Landkreis Heilbronn)


text:
2022 Might Be a Winning Year for Xpeng – and the Stock Is Finally Fairly Priced Now
Automotive Author: Niko Yang Editor: Luke Sheehan Jul 29, 2021 04:01 PM (GMT+8)
On July 7, 2021, the company was listed on the main board of the Hong Kong Stock Exchange under the code '9868.'
● We estimate Xpeng's 2022 revenue to show the value of the stock.
● The methodology includes the forecast of sales of P7, G3&G3i and the upcoming P5 and SUV models.
● The results indicate that the stock is currently fairly priced.
● Risks primarily come from supply chain and market regulation, but remain controllable.
With the current global chip shortage, most major auto OEMs have suffered from a lack of electronic supplies. Amid these concerns, China's EV sales are burgeoning, with light EV sales hitting 241,000, or 15% of total light vehicles sales in June, 2021. Among the country's EV pioneers, Xpeng (XPEV:NYSE) has recently presented some positive results: its half-year delivery number has surpassed last year's figure. This article presents a forecast of the company's EV sales in 2022 and evaluates its stock by analyzing each model of Xpeng and using the valuation multiples.
Model-level breakdown
● P7 is Xpeng's hit product. Simplifying the modelling, we project the sales of P7 to increase by 184, 100 and 50 units month-on-month until 2023; 184 is the average monthly increase since the model's launch, while the incremental decrease is due to the upcoming P5 and 2022 SUV models. The average selling price will be around CNY 250,000, the same as in 2020.
● G3&G3i are the oldest models of Xpeng. The updated version G3i transformed into a more unified family design and attracted more sales. We estimate G3 and G3i will keep lifting sales volume by 46 per month during the same period. The average selling price will be around CNY 150,000 per unit.
● P5 will shoulder the company's expectations to become a family sedan. We estimate P5's first-month delivery number in October will be at around 1,000, referring to P7's data. Then the delivery figure will increase by 143 units per month, of which 100 will be at the cost of P7 sales declining, as the two models compete with each other, and 43 is organic growth. Based on the official price starting from CNY 160,00 to CNY 230,000, we predict the ASP will be at CNY 190,000.
● Xpeng is planning to launch a new SUV model. The SUV has a family design 'X' logo that brings its length to 4,800 mm. The car design shares the same platform as the P7, the Edward platform. In addition, it will be equipped with premium specifications like XPilot 4.0 and air suspension. Some industry experts predict the price will be around CNY 300,000. We assume Xpeng will finish its launch day by September 2022. The first-month sale will be 300 units, which will increase by 145 units per month similar to the sales trajectory of NIO's ES6.
● Apart from EV sales, other services will account for 5% of total revenue. The 2022 EV sales won't be significantly impacted by the chip shortage.
To sum up, Xpeng's 2022 revenue is projected to reach USD 4.3 billion (CNY 28 billion). Specifically, the company will sell 122,253 vehicles to make USD 4.1 billion topline, and USD 0.25 billion will be from other services. According to the Street's expectations, the stock is priced at 16, 8.8, 5.6, 4, 2.9 forward PS ratios by 2025. We select 9x as the 2022 multiples. Thus, the market cap will be USD 38.7 billion, around 10% up from the market cap on July 27, 2021.
Although the expectations for Xpeng are rather bright, the whole industry is facing the chip shortage problem – that is also the biggest threat to Xpeng. For NEV companies, production is challenging while orders are packed. Through our research, we found that most auto stakeholders in China expect the imbalance to last through 2021, affecting the global light-vehicle sales by 2.5-5.0%, but recover slightly in 2022.
The edtech sector's regulatory update drove the recent sell-off in Chinese concept stocks. However, this crackdown won't be a long-term issue for EV innovators like Xpeng. According to Bloomberg, the government's motivation is to cut family workloads to turn the declining birth rates up. On the other hand, the 'Made in China 2025' scheme supports EV development radically. So the policy will rather play a positive role in the new energy vehicle market in the long term.
Up to the present, Xpeng has been on the right track, leveraging business through unified family designs, new stores opening, capacity boost and charging facilities build-up. The company's 2022 revenue would be a realistic basis for stocks to start . The most significant potential risk at present is the capacity problem caused by supply chain shortages. Investors should keep an eye on this topic in the company's upcoming Q2 earnings conference.
Xpeng Motors
Selected reportsMore
WIA2020 | Next 50 in Global Tech: Automotive and Mobility
Engines and Pioneers: China's Auto Industry Heads Towards a New Decade
EqualOcean Analysis
Tesla, NIO, Others' EV Charging Ecosystems Likely To Fully Enmesh in China
Tesla Can Deal with Supply Chain Shortage, Unlike Most Chinese Peers
Xpeng's P5 Is The Next Killer Model in China's Booming EV Space
Xpeng 4Q 2020 Updates: New Model, Growing Capacity, XPILOT and Market Expansion
Automotive sector


text:
International Trade Union Confederation
Building Workers' Power
Frontline campaigns
Democracies for people
A New Social Contract for Recovery and Resilience
Climate- and Employment-Proof Our Work with Just Transition
Peace, Democracy and Rights
Regulating Economic Power
Global Shifts - Just Transitions
Child labour/Forced labour
Development (TUDCN)
Gender-based violence at work
Human and trade union rights
Sport and Rights
Economic and Social Policy
Organising for Decent Jobs – Formalising Informal Work
The power of workers' organising to fight the desperation of the informal sector is revealed in a new report published by Equal Times with case studies from 17 countries documenting union action to formalise informal jobs
The report outlines the success of union organising to transform the lives of waste recycling workers in Brazil, moto-taxi drivers in Rwanda, domestic workers in Belgium and Lebanon, street vendors in Ghana, artists in Uruguay and workers from many other sectors in many other countries. The work of the Indian Self-Employed Women's Association SEWA is highlighted in a country where 92 per cent of the economy is informal, while in the USA, worker-focused alternatives to the so-called "gig" economy, where internet platforms are being used by businesses to break down the employment relationship, are examined.
Sharan Burrow, ITUC General Secretary, said: "While debate rages about the future of work at high-level meetings and conferences around the world, people are getting on with the job of shaping the future by organising unions and building workers' power to lift the more than 40 per cent of the world's workforce into formal, decent employment. Anyone who doubts the effectiveness of workers exercising their fundamental right to organise should be convinced of its value once they have read the hard evidence that this report shows."
A common strand through the report is the use of an international instrument, ILO Recommendation 204, which sets out how countries should formalise informal economic activity.
"This is a clear example of the benefits that international labour standards can bring, when governments fulfil their responsibilities and workers are free to organise. With swathes of the global labour market outside the scope of regulation and worker protection, and dangerous informality trends in developing and industrialised countries, there is an urgent need for the lessons from this report and so many other examples of successful union organising to be spread far and wide. The world is experiencing huge levels of inequality and insecurity which are having severe impacts on families and communities, and posing a real threat to a sustainable economy and to democracy and human rights. All of the great advances in history have been made by people working together, and this report shows how the power of workers' organising can deliver decent work now and in the future," said Burrow.
For more information, please contact the ITUC Press Department on +32 2 224 02 10 or [email protected]
Equal Times
News, opinion & in depth reports
Be the first to know – sign up to our breaking news email alerts
The ITUC represents 200 million workers in 163 countries and territories and has 332 national affiliates.
Calendar |


San Francisco: Google revealed first Gmail redesign since 2013. According to sources, changes were made to cater better offline functionality and security. The redesign is also crucial for Gmail to effectively compete with Microsoft Outlook.
Google decided to make an update to the G Suite Workplace Bundle. Earlier, G Suite also added spreadsheet and instant messaging features. With Gmail, Google said it rebuilt email stockpiling databases, bound together three dueling frameworks for matching up messages crosswise over gadgets and overhauled PCs supporting the administration. That move to Google's self-created Tensor processing chip empowers features such as "nudges" to react to overlooked messages and"suggested replies" to the messages.
Google's Bank said the update was required principally to give offline access to up to ninety days of messages for clients who utilize the feature. People who use "confidential" option when sending an email can time-constrain its entrance to beneficiaries and furthermore require they enter a one-time password sent to their telephones to peruse it.
The new setting does not abrogate corporate email maintenance arrangements or present new snags to law requirement. Technical analysts believe that Google's move will result in a healthier competition between Google and Microsoft.


If your state does not offer free quit smoking products through its statewide tobacco cessation program, there is still the possibility to get free quit smoking products through Medicaid coverage. Because of the recent expansion of Medicaid due to the implementation of the Affordable Care Act, those states that have accepted federal money are required to also cover tobacco cessation products, meaning that you could get nicotine patches and gum through your Medicaid insurance.
GD Smoking Electronic Cigarettes, Too Handsome?
GD smoking electronic cigarettes, too handsome?!
There is a fundamental difference between cigarettes and electronic cigarettes. Cigarette smoke is the solid particles produced after combustion. The smoke of electronic smoke is the mist produced by liquid atomization at high temperature. Electronic cigarette smoke is not a smoking cessation product. It can only be regarded as a smoking cessation aid, but only a substitute for tobacco.
Electronic cigarette than real smoke fortunately where, in brief, there are so few points: 1.electronic cigarettes do not contain tar, carbon monoxide and other harmful substances, he only contains nicotine, and nicotine itself does not have much harm, it is only addictive thing. 2. electronic cigarettes almost do not produce second-hand smoke, will not make people feel bad fog.
When an electronic cigarette heats up steam, when it comes to lung cancer, electronic cigarettes are certainly much safer than traditional cigarettes. If you want to and traditional cigarettes than harm, it should be on harm of manufacturing raw materials, oil and other ancillary products more, especially the harm of inferior electronic cigarette.
Understand the harm of electronic smoke and its principle, precautionary measure is very clear. 1. try to choose the proper electronic cigarette manufacturers, especially manufacturers to choose proper smoke. 2. smoke generally marked the nicotine content, choose low nicotine content and the choice of oil smoke, not cool high nicotine content of tar.


John Lennon Signed White Album Cover. Most often referred to as The White Album and released at the height of the Beatle's popularity, their 1968 self-titled LP still stands as one of the major accomplishments in popular music and ranked #10 on Rolling Stone's list of the 500 greatest albums of all time. This particular copy of the album cover was signed on the back quite nicely by John Lennon in red ballpoint. The signature was obtained in May 1975, when Lennon appeared as a celebrity guest host for the Helping Hands Marathon at WFIL Television studios in Philadelphia. Also included is a picture of Lennon signing the album cover, and a letter of authenticity. In Very Fine condition with some mild to moderate discoloration and soiling. Accompanied by LOA from PSA/DNA.


It's time to add another line to the long list of accomplishments for Monmouth University product Ryan Kinne. The Naugatuck, CT native, who helped lead the Hawks to national prominence under head coach Robert McCourt, is headed to the pros with his hometown team, the New England Revolution.
For Kinne, playing in MLS is simply fulfilling another goal – one he felt was never out of reach.
That confidence served Kinne well as he parlayed an impressive high school career into a standout college career with the Monmouth Hawks. After earning First Team All-American honors during his final two years, professional coaches took notice. Thus, it hardly came as a surprise when his name was called in the third round of the MLS SuperDraft, selected with the 42nd overall pick by the Revs.
Interestingly, Kinne expected to get the call much earlier and left the Baltimore Convention Center, where the draft was held, out of frustration after his name wasn't called in the first two rounds.
That disappointment didn't last long. When Kinne eventually learned he was going to join the Revolution – the same team he had grown up rooting for – the despair quickly faded.
Growing up, Kinne's favorite player was former Revolution and U.S. International striker Joe-Max Moore. A chance meeting with the Revolution legend cemented his admiration for his boyhood hero.
It should come as no surprise then that the 5-8 goalscorer, who can play up front, as well as across the midfield, plays a style similar to Moore's. The two share a similarly small stature, but the resemblance doesn't stop there: both show uncommon poise on the attack, employ their pace to take on defenders, often find the back of the net in a myriad of manners, and do well to create chances for teammates.
Now Kinne will be hoping to emulate Moore's success on the professional level.
Unlike many other college prospects, who's journeys to top flight soccer are often littered with setbacks and valleys, Kinne's path to the pros bursted with success at every stop. Constantly under the spotlight, the 22-year-old has always risen to the occasion. Back at Naugatuck High School, Kinne dominated the competition, as recruiters crammed the stands. In his senior year, he led the state in scoring, steered his school to the league championship, and earned NSCAA Connecticut State Player of the Year. When it was all said and done, Kinne finished his high school career with a school-record 79 goals and 26 assists in just three years.
McCourt was one of several coaches keeping an eye on Kinne. McCourt had already put Monmouth on the soccer map, taking the men's soccer team from an eighth place finish in 2004 to first in 2005. The Hawks were on their way to back-to-back undefeated seasons in conference play and the Northeast Conference title in 2006 when he saw Kinne as a player that could help take them to the next level.
But it wasn't just Kinne's incredible scoring record that impressed McCourt. Kinne's technical ability and speed seemed the perfect fit for Monmouth's new style of play.
Indeed, the style of play employed by McCourt allowed the enterprising Kinne the chance to shine.
It didn't take long to sell Kinne on the school, either. Monmouth wasn't initially on Kinne's radar, but one meeting with McCourt changed all that.
For Kinne and McCourt, the decision couldn't have worked out any better. Kinne immediately made his mark with the team as a freshman, starting 15 of the 16 games he played and tallying three goals and two assists along the way. Although the 15 starts as a freshman were impressive, it was actually the manner in which Kinne scored one of his three goals that McCourt truly realized he had an exceptional player on his hands.
It was a sign of things to come for Kinne. The attacker continued to show his penchant for the dramatic throughout his time with the Hawks.
More importantly, those big moments helped usher greater ones for the team. During Kinne's collegiate career, the Hawks captured the NEC regular season title in each of his four seasons, and a pair of NEC Tournament Championships during his junior and senior years. Monmouth was ranked as high as #5 in the NSCAA nationwide rankings during that stretch, and earned NCAA tournament berths in 2009 and 2010.
After a series of storybook seasons at Monmouth, Kinne finished his career with 35 goals and 21 assists. His impressive statistics wouldn't go unnoticed. In addition to his two All-American selections, he earned NEC Player of the Year twice and was a two-time semifinalist for the Hermann Trophy, the award given to the best Division I soccer player in the country.
As if a remarkable collegiate resume hadn't provided enough evidence of his exceptional talent, Kinne was given one more chance to impress the scouts at the MLS Combine, which took place earlier this month. The Combine features the best soccer players from around the country, and quite often separates the poseurs from the pros. During the glorified tryout, 80 or so players are divided into four teams, creating a difficult situation where prospects attempt to impress coaches while playing with unfamiliar teammates. It was a situation that didn't deter Kinne in the slightest. Once again, Kinne was his usual confident self, as he redirected a cross into the far corner of the net from close range for one of his team's three goals during the showcase.
It should come as no surprise Kinne managed to rise to the occasion at the Combine. He's been doing that at every level his whole career.
Now, his toughest task awaits: earning a roster spot with the Revs once the preseason commences on January 31st. While McCourt feels he's likely to make it as a midfielder at the professional, Kinne's versatility to play up front, as well as anywhere in the midfield, should help his case.
If Kinne's career thus far is any indication, expect Kinne's plan to land him a spot on the roster come opening day March 20th in Los Angeles. And where better for a player with Kinne's flair for the dramatic to make his professional debut than – you guessed it – Hollywood?
I like the sound of this kid too! Part of me wants to believe we can just slot these promising youngsters in to the starting lineup to help deal with our goalscoring woes… but I still think we could really use an experienced playmaker up front, from whom these guys can learn.
All the best Ryan….I'll be watching and rooting you on.


Welcome to the Richfield Church of Christ - a vibrant community of faith whose mission is to exalt God, share Christ, grow in Christ and serve through the Spirit. Whether you're looking for a Church home or visiting the Twin Cities, we invite you to join us at one of services.
©2017 Richfield Church of Christ. All Rights Reserved. Powered by Squarespace.


We've just posted the images from the 2018 SDCC Marvel Sideshow display booth.
Yeah, statues are way out of my price range to. Even more than Hot Toys.
They all look great. Sideshow figures are a bit out of my price range, if I could afford any of them I would love to have the Black Widow, the figure looks amazing and I love the pose they have her in.
I think that those Mark Brook's designs for the Spider-verse statues are pretty awesome.
That Deadpool bust looks amazing with all of the detail put in it.
I would not want that Wolverine bust in my house.
I love that Civil War opened the floodgates formore Romita Sr. proportioned Spider-man merch.
Im not sure Im really feeling those busts they look a bit, creepy, I guess but, most of the rest of the statues look really nice... Plus, any excuse to see another iteration of Spider-Gwen, is fine by me.


text:
Q: Images in posters I am using the template from Elena Botoeva to create an A0 poster. How do I insert figures (pdf) into each node? I am guessing that \usepackage{graphicx} will be needed but it keeps giving errors saying that there are too many closing brackets, }.

A: First include the graphics package in the preamble.
\usepackage{graphics}

Then just use
\includegraphics{oohapicture}

within one of the \blocknode environments that are defined.
For example, to include a picture in the Personalizing the Poster section of the example, use this:
\blocknode {Personalizing the Poster}%
{It is possible to adjust the layout of the poster. To impose your own setting, you can use these macros:

\includegraphics{oohapicture}

\begin{itemize}
...

and it should work fine.
If you have two files with different extensiosn (e.g. .eps and .pdf), and you desperately want to use the pdf, just add the extension to the file name:
\includegraphics{oohapicture.pdf}


Handy Stitch Sewing Machine Online In Pakistan - It Is No Surprise For Us That Handy Stitch Sewing Machines Are A New Trend Nowadays. These Small Portable Sewing Machines Are Easy To Use And Great For Everyone. These Are Awesome For Travelers, Busy People, Etc. As These Machines Fix Your Everyday Stitching Problems Within Minutes. Handy Stitch Sewing Machine In Pakistan Is Now Available Online At Getnow.pk. It Is So Embarrassing That When You Are In A Family Or Business Trip And Planning To Wear Your Favorite Dress Then Unfortunately You Find A Tear On Your Shirt. Now What To Do? Then Comes The Use Of This Small Portable Sewing Machine. It Is Very Lightweight So That You Can Carry It Anywhere, During Traveling Or At Your Homes.
These Small Devices Are Flexible, Affordable And Perfect For Simple Projects. All Types Of Fabrics Can Be Sewed By Using It. If You Love To Sew Clothes While Traveling And Doing Other Tasks, Then This Product Is Ideal For You. Now No More Stitching Problems Will Disturb You As It Is Inexpensive And Easy To Store. Getnow Shopping Store Is Offering The Best Available Handy Stitch Sewing Machine Price In Pakistan And That Too With 7 Days Warranty And Cash On Delivery Offer. This Is A Handy Partner For Every Woman And For Any Home. You Just Use This And The Results Will Be Outstanding.